Condition
Mesothelioma
Estimated Enrollment: 17
Age Group: 21 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: OS-MES-P2-01
Study First Received: June 20, 2012
Last Updated: March 28, 2016
Estimated Primary Completion Date: August 2018
Primary Outcome Measures:
Adverse events and serious adverse events occurence|overall survival time
Sponsors and Collaborators:
Oshadi Drug Administration
Website Link: https://ClinicalTrials.gov/show/NCT01627795
